We are almost there ...
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
12 March, 2025•6 min
0
12 March, 2025•6 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Health
You may also like
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
Business
Natco just can’t kick its high-risk, high-gain game plan
CEO Rajeev Nannapaneni’s oft-used strategy of mounting patent challenges in the US got the pharma company its latest blockbuster Revlimid. But what after sales fall off a cliff?
Business
Sailesh Hiranandani’s SRAM & MRAM Group is running a global con
The purported conglomerate has signed a high-profile agreement to invest in SpiceJet’s cargo business, promised to set up a high-tech chip unit in Odisha and backed two Web3 startups to unicorn valuations. In reality, it is all smoke and mirrors.
